Larvol Delta - ExpreS2ion-announces-approval-to-initiate-a-Phase-I-clinical-trial-of-ES2BC001-its-novel-therapeutic-vaccine-being-developed-for-HER2expressing-breast-cancer

ES2B-C001 - ExpreS2ion

https://news.cision.com/expres2ion-biotechnologies/r/expres2ion-announces-approval-to-initiate-a-phase-i-clinical-trial-of-es2b-c001--its-novel-therapeut,c4074722

Dec 2, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next